Storrs, CTNCT06912100Now EnrollingIRB Ready

Overweight (BMI > 25) Clinical Trial in Storrs, CT

Access cutting-edge overweight (bmi > 25) treatment through this clinical trial at a research site in Storrs. Study-provided care at no cost to qualified participants.

Sponsored by University of Connecticut

Quick Self-Assessment

See if you qualify for this Storrs location

Preparing your pre-screening questions…

Expert Care in Storrs

Access overweight (bmi > 25) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related overweight (bmi > 25) treatment provided free

Apply for This Storrs Location

Check if you qualify for this overweight (bmi > 25) clinical trial in Storrs, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Storrs

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Storrs site if eligible
  4. 4Begin participation

About This Overweight (BMI > 25) Study in Storrs

This is a pilot research study to investigate the effects of a probiotic supplement (L. acidophilus, strain TW01) on substances found in the stool and bloodstream, gut bacteria composition, body composition, as well as any relationship of these substances with markers of inflammation. Lactobacillus acidophilus is commonly found in a variety of fermented foods, including yogurt, cheese, and kefir, due to its ability to produce lactic acid and other substances. This bacterium is generally well-tolerated in healthy individuals and has a longstanding history of safe use. The investigators are doing this pilot study to see if a particular probiotic, called L. acidophilus (strain TW01) and isolated from fermented coffee grounds, can make a positive difference in human gut and overall health. Specifically, the investigators want to look at how this probiotic affects certain substances in human stool and blood, the makeup of the bacteria in the gut, and aspects of body composition. The investigators are also interested in whether these changes relate to markers of inflammation, which can tell us more about their impact on overall health. This probiotic strain has been shown in other studies to be safe and well tolerated, and the investigators hope our research will help us better understand how it works and whether it might support health in humans.

Sponsor: University of Connecticut

Who Can Participate

Inclusion Criteria

Age 18-60 years
Body mass index (BMI) between 28 kg/m2 and 40 kg/m2
Waist circumference ≥ 88 cm or 35 inches for women, ≥ 102 cm or 40 inches for men
Willing to consume experimental capsules daily
Willing to prepare and consume the delivered meal kits
Do not fit any

Exclusion Criteria

Self-reported history of immunodeficiency, major gastrointestinal surgery, renal or liver disease, diabetes, heart disease, stroke, peripheral artery/vascular disease, cancer, eating disorders, gut-associated pathologies, autoimmune diseases, pacemaker, thyroid disease, gallbladder disease, chronic inflammatory diseases, scleroderma, blood clotting disorders, intravenous drug use
Weight changes \> 10% over the last 4 weeks
Oral antibiotics and/or probiotics use up to 1 month prior to study and during study
Currently taking GLP-1 analogues (e.g., Ozempic), anti-inflammatory medications (e.g., corticosteroids), daily use of nonsteroidal anti-inflammatory drugs (NSAIDs) (occasional use is permitted), medications which primarily affect blood clotting (e.g., warfarin), or any medications that suppress the immune system.
Dairy allergy
Currently pregnant or breast-feeding

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Storrs?

Yes, this clinical trial (NCT06912100) has an active research site in Storrs, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Overweight (BMI > 25) Treatment Options in Storrs, CT

If you're searching for overweight (bmi > 25) treatment options in Storrs, CT, this clinical trial (NCT06912100) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Storrs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overweight (bmi > 25) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all overweight (bmi > 25) clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Storrs, CT

See all heart attack clinical trials recruiting in Storrs — not just this study.

Browse Heart Attack Trials in Storrs

Ready to Join in Storrs?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Storrs, CT